25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Implantica AG
Buy, Hold or Sell?

Let's analyze Implantica together

I guess you are interested in Implantica AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Implantica AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Implantica AG

I send you an email if I find something interesting about Implantica AG.

1. Quick Overview

1.1. Quick analysis of Implantica (30 sec.)










1.2. What can you expect buying and holding a share of Implantica? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.39
Expected worth in 1 year
kr-4.68
How sure are you?
26.3%

+ What do you gain per year?

Total Gains per Share
kr-5.08
Return On Investment
-13.3%

For what price can you sell your share?

Current Price per Share
kr38.10
Expected price per share
kr33.00 - kr46.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Implantica (5 min.)




Live pricePrice per Share (EOD)
kr38.10
Intrinsic Value Per Share
kr-15.41 - kr-18.23
Total Value Per Share
kr-15.02 - kr-17.83

2.2. Growth of Implantica (5 min.)




Is Implantica growing?

Current yearPrevious yearGrowGrow %
How rich?$10.1m$115.5m-$104.6m-953.1%

How much money is Implantica making?

Current yearPrevious yearGrowGrow %
Making money-$538.7k-$5.2m$4.6m868.6%
Net Profit Margin-1,408.5%-1,944.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Implantica (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Implantica?

Welcome investor! Implantica's management wants to use your money to grow the business. In return you get a share of Implantica.

First you should know what it really means to hold a share of Implantica. And how you can make/lose money.

Speculation

The Price per Share of Implantica is kr38.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Implantica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Implantica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.39. Based on the TTM, the Book Value Change Per Share is kr-1.27 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Implantica.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.000.0%0.000.0%-0.020.0%-0.010.0%-0.010.0%
Usd Book Value Change Per Share0.000.0%-0.12-0.3%-0.020.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.12-0.3%-0.020.0%0.000.0%0.000.0%
Usd Price Per Share2.99-2.50-2.77-4.50-4.50-
Price to Earnings Ratio-366.38--377.38--36.63--200.93--200.93-
Price-to-Total Gains Ratio-1,757.46--1,036.57--197.90--418.99--418.99-
Price to Book Ratio83.64-65.37-15.94-33.28-33.28-
Price-to-Total Gains Ratio-1,757.46--1,036.57--197.90--418.99--418.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.45567
Number of shares289
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.120.00
Usd Total Gains Per Share-0.120.00
Gains per Quarter (289 shares)-33.280.54
Gains per Year (289 shares)-133.112.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-133-14302-8
20-266-27604-6
30-399-40907-4
40-532-54209-2
50-666-6750110
60-799-8080132
70-932-9410154
80-1065-10740176
90-1198-12070208
100-1331-134002210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.019.00.00.0%0.019.00.00.0%0.019.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.013.01.026.3%5.013.01.026.3%5.013.01.026.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.019.00.0%0.00.019.00.0%0.00.019.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.013.01.026.3%5.013.01.026.3%5.013.01.026.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Implantica AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-1.270+6661%-0.196+942%0.021-190%0.021-190%
Book Value Per Share--0.3950.427-8%4.502-91%4.154-91%4.154-91%
Current Ratio--23.46822.842+3%30.607-23%29.552-21%29.552-21%
Debt To Asset Ratio--0.0370.039-4%0.030+25%0.096-61%0.096-61%
Debt To Equity Ratio--0.0380.039-4%0.030+24%0.159-76%0.159-76%
Dividend Per Share----0%-0%-0%-0%
Eps---0.023-0.021-7%-0.210+830%-0.140+520%-0.140+520%
Free Cash Flow Per Share---0.266-0.254-4%-0.161-39%-0.259-3%-0.259-3%
Free Cash Flow To Equity Per Share---0.269-0.257-4%-0.168-37%0.263-202%0.263-202%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---18.227--------
Intrinsic Value_10Y_min---15.411--------
Intrinsic Value_1Y_max---0.930--------
Intrinsic Value_1Y_min---0.913--------
Intrinsic Value_3Y_max---3.477--------
Intrinsic Value_3Y_min---3.306--------
Intrinsic Value_5Y_max---6.848--------
Intrinsic Value_5Y_min---6.298--------
Market Cap--9342638085.0007806469578.275+20%8634772481.400+8%12277534018.282-24%12277534018.282-24%
Net Profit Margin---11.507-14.085+22%-19.448+69%-46.452+304%-46.452+304%
Operating Margin---10.594-14.931+41%-18.179+72%-44.707+322%-44.707+322%
Operating Ratio--11.59417.524-34%21.963-47%44.945-74%44.945-74%
Pb Ratio96.562+13%83.63765.368+28%15.940+425%33.279+151%33.279+151%
Pe Ratio-423.000-15%-366.378-377.382+3%-36.634-90%-200.929-45%-200.929-45%
Price Per Share38.100+13%33.00027.575+20%30.500+8%49.597-33%49.597-33%
Price To Free Cash Flow Ratio-35.872-15%-31.071-27.516-11%-47.534+53%-61.196+97%-61.196+97%
Price To Total Gains Ratio-2029.063-15%-1757.456-1036.575-41%-197.900-89%-418.985-76%-418.985-76%
Quick Ratio--22.87722.429+2%33.459-32%33.110-31%33.110-31%
Return On Assets---0.055-0.047-14%-0.118+115%-0.057+3%-0.057+3%
Return On Equity---0.056-0.048-14%-0.120+115%-0.066+18%-0.066+18%
Total Gains Per Share---0.019-1.270+6661%-0.196+942%0.021-190%0.021-190%
Usd Book Value--10131643.50010976854.125-8%115597546.341-91%83538873.197-88%83538873.197-88%
Usd Book Value Change Per Share---0.002-0.115+6661%-0.018+942%0.002-190%0.002-190%
Usd Book Value Per Share--0.0360.039-8%0.408-91%0.377-91%0.377-91%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.002-7%-0.019+830%-0.013+520%-0.013+520%
Usd Free Cash Flow---6818180.688-6511273.901-5%-4136070.907-39%-3931118.711-42%-3931118.711-42%
Usd Free Cash Flow Per Share---0.024-0.023-4%-0.015-39%-0.023-3%-0.023-3%
Usd Free Cash Flow To Equity Per Share---0.024-0.023-4%-0.015-37%0.024-202%0.024-202%
Usd Market Cap--847377274.310708046790.750+20%783173864.063+8%1113572335.458-24%1113572335.458-24%
Usd Price Per Share3.456+13%2.9932.501+20%2.766+8%4.498-33%4.498-33%
Usd Profit---578212.500-538712.650-7%-5217936.888+802%-2846344.421+392%-2846344.421+392%
Usd Revenue--50247.80043127.850+17%285003.499-82%114619.669-56%114619.669-56%
Usd Total Gains Per Share---0.002-0.115+6661%-0.018+942%0.002-190%0.002-190%
 EOD+3 -3MRQTTM+16 -17YOY+16 -175Y+12 -2110Y+12 -21

3.3 Fundamental Score

Let's check the fundamental score of Implantica AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-423.000
Price to Book Ratio (EOD)Between0-196.562
Net Profit Margin (MRQ)Greater than0-11.507
Operating Margin (MRQ)Greater than0-10.594
Quick Ratio (MRQ)Greater than122.877
Current Ratio (MRQ)Greater than123.468
Debt to Asset Ratio (MRQ)Less than10.037
Debt to Equity Ratio (MRQ)Less than10.038
Return on Equity (MRQ)Greater than0.15-0.056
Return on Assets (MRQ)Greater than0.05-0.055
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Implantica AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.697
Ma 20Greater thanMa 5039.995
Ma 50Greater thanMa 10041.380
Ma 100Greater thanMa 20040.973
OpenGreater thanClose37.150
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, the company develops UriControl, a remote controlled artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for the treatment of aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.

Fundamental data was last updated by Penke on 2024-11-14 17:52:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Implantica earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Implantica to the Medical Devices industry mean.
  • A Net Profit Margin of -1,150.7% means that kr-11.51 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Implantica AG:

  • The MRQ is -1,150.7%. The company is making a huge loss. -2
  • The TTM is -1,408.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,150.7%TTM-1,408.5%+257.7%
TTM-1,408.5%YOY-1,944.8%+536.3%
TTM-1,408.5%5Y-4,645.2%+3,236.8%
5Y-4,645.2%10Y-4,645.2%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,150.7%-6.4%-1,144.3%
TTM-1,408.5%-15.3%-1,393.2%
YOY-1,944.8%-15.2%-1,929.6%
5Y-4,645.2%-18.1%-4,627.1%
10Y-4,645.2%-23.4%-4,621.8%
4.3.1.2. Return on Assets

Shows how efficient Implantica is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Implantica to the Medical Devices industry mean.
  • -5.5% Return on Assets means that Implantica generated kr-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Implantica AG:

  • The MRQ is -5.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-4.7%-0.8%
TTM-4.7%YOY-11.8%+7.1%
TTM-4.7%5Y-5.7%+1.0%
5Y-5.7%10Y-5.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.5%-2.1%-3.4%
TTM-4.7%-3.2%-1.5%
YOY-11.8%-4.0%-7.8%
5Y-5.7%-3.0%-2.7%
10Y-5.7%-4.1%-1.6%
4.3.1.3. Return on Equity

Shows how efficient Implantica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Implantica to the Medical Devices industry mean.
  • -5.6% Return on Equity means Implantica generated kr-0.06 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Implantica AG:

  • The MRQ is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.6%TTM-4.8%-0.8%
TTM-4.8%YOY-12.0%+7.2%
TTM-4.8%5Y-6.6%+1.8%
5Y-6.6%10Y-6.6%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.6%-2.4%-3.2%
TTM-4.8%-3.8%-1.0%
YOY-12.0%-4.2%-7.8%
5Y-6.6%-4.4%-2.2%
10Y-6.6%-5.7%-0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Implantica AG.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Implantica is operating .

  • Measures how much profit Implantica makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Implantica to the Medical Devices industry mean.
  • An Operating Margin of -1,059.4% means the company generated kr-10.59  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Implantica AG:

  • The MRQ is -1,059.4%. The company is operating very inefficient. -2
  • The TTM is -1,493.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,059.4%TTM-1,493.1%+433.7%
TTM-1,493.1%YOY-1,817.9%+324.8%
TTM-1,493.1%5Y-4,470.7%+2,977.6%
5Y-4,470.7%10Y-4,470.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,059.4%-10.8%-1,048.6%
TTM-1,493.1%-16.8%-1,476.3%
YOY-1,817.9%-13.0%-1,804.9%
5Y-4,470.7%-17.4%-4,453.3%
10Y-4,470.7%-19.8%-4,450.9%
4.3.2.2. Operating Ratio

Measures how efficient Implantica is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 11.59 means that the operating costs are kr11.59 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Implantica AG:

  • The MRQ is 11.594. The company is inefficient in keeping operating costs low. -1
  • The TTM is 17.524. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.594TTM17.524-5.930
TTM17.524YOY21.963-4.439
TTM17.5245Y44.945-27.422
5Y44.94510Y44.9450.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5941.324+10.270
TTM17.5241.340+16.184
YOY21.9631.326+20.637
5Y44.9451.373+43.572
10Y44.9451.321+43.624
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Implantica AG.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Implantica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 23.47 means the company has kr23.47 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Implantica AG:

  • The MRQ is 23.468. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.842. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ23.468TTM22.842+0.627
TTM22.842YOY30.607-7.765
TTM22.8425Y29.552-6.710
5Y29.55210Y29.5520.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ23.4682.573+20.895
TTM22.8422.666+20.176
YOY30.6072.922+27.685
5Y29.5523.393+26.159
10Y29.5523.470+26.082
4.4.3.2. Quick Ratio

Measures if Implantica is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Implantica to the Medical Devices industry mean.
  • A Quick Ratio of 22.88 means the company can pay off kr22.88 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Implantica AG:

  • The MRQ is 22.877. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 22.429. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ22.877TTM22.429+0.448
TTM22.429YOY33.459-11.031
TTM22.4295Y33.110-10.681
5Y33.11010Y33.1100.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ22.8771.528+21.349
TTM22.4291.698+20.731
YOY33.4591.875+31.584
5Y33.1102.296+30.814
10Y33.1102.545+30.565
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Implantica AG.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Implantica assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Implantica to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.04 means that Implantica assets are financed with 3.7% credit (debt) and the remaining percentage (100% - 3.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Implantica AG:

  • The MRQ is 0.037. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.039. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.037TTM0.039-0.002
TTM0.039YOY0.030+0.009
TTM0.0395Y0.096-0.057
5Y0.09610Y0.0960.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0370.407-0.370
TTM0.0390.398-0.359
YOY0.0300.360-0.330
5Y0.0960.437-0.341
10Y0.0960.457-0.361
4.5.4.2. Debt to Equity Ratio

Measures if Implantica is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Implantica to the Medical Devices industry mean.
  • A Debt to Equity ratio of 3.8% means that company has kr0.04 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Implantica AG:

  • The MRQ is 0.038. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.039. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.038TTM0.039-0.002
TTM0.039YOY0.030+0.009
TTM0.0395Y0.159-0.120
5Y0.15910Y0.1590.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0380.552-0.514
TTM0.0390.589-0.550
YOY0.0300.530-0.500
5Y0.1590.630-0.471
10Y0.1590.698-0.539
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Implantica generates.

  • Above 15 is considered overpriced but always compare Implantica to the Medical Devices industry mean.
  • A PE ratio of -366.38 means the investor is paying kr-366.38 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Implantica AG:

  • The EOD is -423.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -366.378. Based on the earnings, the company is expensive. -2
  • The TTM is -377.382. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-423.000MRQ-366.378-56.622
MRQ-366.378TTM-377.382+11.004
TTM-377.382YOY-36.634-340.747
TTM-377.3825Y-200.929-176.453
5Y-200.92910Y-200.9290.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-423.000-1.069-421.931
MRQ-366.378-1.360-365.018
TTM-377.382-1.961-375.421
YOY-36.634-2.324-34.310
5Y-200.929-2.115-198.814
10Y-200.929-2.205-198.724
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Implantica AG:

  • The EOD is -35.872. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -31.071. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -27.516. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-35.872MRQ-31.071-4.802
MRQ-31.071TTM-27.516-3.554
TTM-27.516YOY-47.534+20.018
TTM-27.5165Y-61.196+33.680
5Y-61.19610Y-61.1960.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-35.872-1.388-34.484
MRQ-31.071-1.767-29.304
TTM-27.516-2.060-25.456
YOY-47.534-5.503-42.031
5Y-61.196-3.739-57.457
10Y-61.196-4.711-56.485
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Implantica is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 83.64 means the investor is paying kr83.64 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Implantica AG:

  • The EOD is 96.562. Based on the equity, the company is expensive. -2
  • The MRQ is 83.637. Based on the equity, the company is expensive. -2
  • The TTM is 65.368. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD96.562MRQ83.637+12.926
MRQ83.637TTM65.368+18.269
TTM65.368YOY15.940+49.428
TTM65.3685Y33.279+32.089
5Y33.27910Y33.2790.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD96.5622.148+94.414
MRQ83.6372.144+81.493
TTM65.3682.339+63.029
YOY15.9403.045+12.895
5Y33.2794.091+29.188
10Y33.2794.612+28.667
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Income Tax Expense  253-243104353-512-58-56



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets116,000
Total Liabilities4,295
Total Stockholder Equity114,094
 As reported
Total Liabilities 4,295
Total Stockholder Equity+ 114,094
Total Assets = 116,000

Assets

Total Assets116,000
Total Current Assets76,507
Long-term Assets39,493
Total Current Assets
Cash And Cash Equivalents 74,029
Net Receivables 551
Inventory 181
Other Current Assets 1,746
Total Current Assets  (as reported)76,507
Total Current Assets  (calculated)76,507
+/-0
Long-term Assets
Property Plant Equipment 926
Intangible Assets 37,581
Long-term Assets Other 986
Long-term Assets  (as reported)39,493
Long-term Assets  (calculated)39,493
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,260
Long-term Liabilities1,035
Total Stockholder Equity114,094
Total Current Liabilities
Short-term Debt 298
Accounts payable 251
Other Current Liabilities 2,711
Total Current Liabilities  (as reported)3,260
Total Current Liabilities  (calculated)3,260
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,035
Long-term Liabilities  (calculated)0
+/- 1,035
Total Stockholder Equity
Common Stock129,137
Retained Earnings -397,786
Accumulated Other Comprehensive Income 382,745
Other Stockholders Equity -2
Total Stockholder Equity (as reported)114,094
Total Stockholder Equity (calculated)114,094
+/-0
Other
Cash and Short Term Investments 74,029
Common Stock Shares Outstanding 283,110
Liabilities and Stockholders Equity 116,000
Net Debt -73,308
Short Long Term Debt Total 721



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
19,675
0
19,352
109,919
116,619
113,730
168,756
164,690
163,131
159,691
157,489
156,680
148,407
142,471
139,299
135,430
129,951
122,126
116,000
116,000122,126129,951135,430139,299142,471148,407156,680157,489159,691163,131164,690168,756113,730116,619109,91919,352019,6750
   > Total Current Assets 
0
1,589
34
917
91,028
98,023
93,889
147,852
136,189
133,362
126,675
122,371
119,333
110,071
103,447
99,379
95,151
89,654
82,244
76,507
76,50782,24489,65495,15199,379103,447110,071119,333122,371126,675133,362136,189147,85293,88998,02391,028917341,5890
       Cash And Cash Equivalents 
0
34
-34
311
90,507
97,511
93,294
147,289
89,327
84,333
76,963
71,331
66,078
108,951
102,331
98,182
93,819
87,922
80,082
74,029
74,02980,08287,92293,81998,182102,331108,95166,07871,33176,96384,33389,327147,28993,29497,51190,507311-34340
       Short-term Investments 
0
0
68
0
0
0
0
0
46,168
48,403
48,685
50,201
52,301
0
0
0
0
0
0
0
000000052,30150,20148,68548,40346,168000006800
       Net Receivables 
0
47
0
49
20
23
48
76
55
13
139
118
158
88
148
211
165
432
453
551
55145343216521114888158118139135576482320490470
       Other Current Assets 
0
1,250
0
288
238
307
380
352
490
476
672
599
644
866
810
727
914
989
1,495
1,746
1,7461,49598991472781086664459967247649035238030723828801,2500
   > Long-term Assets 
0
18,086
-34
18,435
18,891
18,596
19,841
20,904
28,501
29,769
33,016
35,118
37,347
38,336
39,024
39,920
40,279
40,297
39,882
39,493
39,49339,88240,29740,27939,92039,02438,33637,34735,11833,01629,76928,50120,90419,84118,59618,89118,435-3418,0860
       Property Plant Equipment 
0
223
0
162
136
287
265
253
274
324
1,600
1,545
1,484
1,371
1,278
1,232
1,182
1,147
1,002
926
9261,0021,1471,1821,2321,2781,3711,4841,5451,60032427425326528713616202230
       Intangible Assets 
0
96
0
16,828
17,372
35
18,218
19,034
26,352
25
30,436
32,593
34,883
14
36,758
37,701
38,110
92
37,894
37,581
37,58137,8949238,11037,70136,7581434,88332,59330,4362526,35219,03418,2183517,37216,8280960
       Other Assets 
0
186,637
0
15,135
14,527
183,651
13,903
16,411
19,007
302,901
10,196
10,504
10,659
412,817
11,124
11,617
11,400
0
0
0
00011,40011,61711,124412,81710,65910,50410,196302,90119,00716,41113,903183,65114,52715,1350186,6370
> Total Liabilities 
0
8,146
0
10,255
7,101
1,733
1,831
2,903
3,312
3,214
2,992
3,495
4,186
4,320
4,254
4,578
5,107
4,905
5,105
4,295
4,2955,1054,9055,1074,5784,2544,3204,1863,4952,9923,2143,3122,9031,8311,7337,10110,25508,1460
   > Total Current Liabilities 
0
4,826
0
6,676
7,101
1,539
1,668
2,775
3,220
3,214
2,992
3,495
4,186
3,236
3,244
3,547
4,061
3,746
4,005
3,260
3,2604,0053,7464,0613,5473,2443,2364,1863,4952,9923,2143,2202,7751,6681,5397,1016,67604,8260
       Short-term Debt 
0
0
0
5,064
0
0
0
0
0
0
0
0
0
0
0
0
309
314
294
298
2982943143090000000000005,064000
       Accounts payable 
0
1,954
0
2
0
1,123
0
0
17
1,807
0
0
0
1,666
0
0
0
2,110
29
251
251292,1100001,6660001,80717001,1230201,9540
       Other Current Liabilities 
0
2,872
0
1,609
7,101
416
1,668
2,775
3,203
1,407
2,992
3,495
4,186
1,570
3,244
3,547
3,752
1,322
3,682
2,711
2,7113,6821,3223,7523,5473,2441,5704,1863,4952,9921,4073,2032,7751,6684167,1011,60902,8720
   > Long-term Liabilities 
0
3,320
0
3,579
0
194
163
128
92
0
0
0
0
1,084
1,010
1,031
1,046
1,159
1,100
1,035
1,0351,1001,1591,0461,0311,0101,08400009212816319403,57903,3200
       Other Liabilities 
0
0
0
0
150
108
106
97
88
229
1,253
1,211
1,301
267
0
344
0
0
0
0
000034402671,3011,2111,25322988971061081500000
       Deferred Long Term Liability 
0
0
0
0
0
17,306
0
0
0
28,442
0
0
0
35,963
0
0
0
0
0
0
00000035,96300028,44200017,30600000
> Total Stockholder Equity
0
11,529
11,529
9,097
102,668
114,886
111,899
165,853
162,198
160,619
156,489
153,922
152,540
145,554
139,889
136,532
132,390
127,271
119,354
114,094
114,094119,354127,271132,390136,532139,889145,554152,540153,922156,489160,619162,198165,853111,899114,886102,6689,09711,52911,5290
   Common Stock
0
84,073
0
84,073
115,499
120,187
120,187
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137
129,137129,137129,137129,137129,137129,137129,137129,137129,137129,137129,137129,137129,137120,187120,187115,49984,073084,0730
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 
0
128,774
11,529
128,745
195,517
206,052
204,970
252,777
370,962
375,708
376,298
379,404
383,649
380,602
379,394
381,187
382,425
386,195
381,661
382,745
382,745381,661386,195382,425381,187379,394380,602383,649379,404376,298375,708370,962252,777204,970206,052195,517128,74511,529128,7740
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
1,352,734
0
1,348,300
2,053,692
2,070,795
2,098,494
2,565,459
0
0
3,915,173
4,066,487
4,172,627
4,252,089
-20
-59
-59
-2
-2
-2
-2-2-2-59-59-204,252,0894,172,6274,066,4873,915,173002,565,4592,098,4942,070,7952,053,6921,348,30001,352,7340



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,408
Cost of Revenue-1,317
Gross Profit9191
 
Operating Income (+$)
Gross Profit91
Operating Expense-21,931
Operating Income-21,840-21,840
 
Operating Expense (+$)
Research Development8,243
Selling General Administrative14,948
Selling And Marketing Expenses-
Operating Expense21,93123,191
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-21,840
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-24,428-19,252
EBIT - interestExpense = -21,840
-23,670
-23,744
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-21,840-24,428
Earnings Before Interest and Taxes (EBITDA)-21,772
 
After tax Income (+$)
Income Before Tax-24,428
Tax Provision--
Net Income From Continuing Ops--24,428
Net Income-23,744
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses23,248
Total Other Income/Expenses Net-2,5880
 

Technical Analysis of Implantica
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Implantica. The general trend of Implantica is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Implantica's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Implantica AG.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 43.90 < 44.35 < 46.50.

The bearish price targets are: 35.90 > 33.50 > 33.00.

Tweet this
Implantica AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Implantica AG. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Implantica AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Implantica AG. The current macd is -0.75267483.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Implantica price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Implantica. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Implantica price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Implantica AG Daily Moving Average Convergence/Divergence (MACD) ChartImplantica AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Implantica AG. The current adx is 15.15.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Implantica shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Implantica AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Implantica AG. The current sar is 43.90.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Implantica AG Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Implantica AG. The current rsi is 41.70. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Implantica AG Daily Relative Strength Index (RSI) ChartImplantica AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Implantica AG. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Implantica price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Implantica AG Daily Stochastic Oscillator ChartImplantica AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Implantica AG. The current cci is -112.46082884.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Implantica AG Daily Commodity Channel Index (CCI) ChartImplantica AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Implantica AG. The current cmo is -19.63760206.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Implantica AG Daily Chande Momentum Oscillator (CMO) ChartImplantica AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Implantica AG. The current willr is -72.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Implantica is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Implantica AG Daily Williams %R ChartImplantica AG Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Implantica AG.

Implantica AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Implantica AG. The current atr is 1.99254435.

Implantica AG Daily Average True Range (ATR) ChartImplantica AG Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Implantica AG. The current obv is -3,541,989.

Implantica AG Daily On-Balance Volume (OBV) ChartImplantica AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Implantica AG. The current mfi is 27.72.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Implantica AG Daily Money Flow Index (MFI) ChartImplantica AG Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Implantica AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Implantica AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Implantica AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.697
Ma 20Greater thanMa 5039.995
Ma 50Greater thanMa 10041.380
Ma 100Greater thanMa 20040.973
OpenGreater thanClose37.150
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Implantica with someone you think should read this too:
  • Are you bullish or bearish on Implantica? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Implantica? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Implantica AG

I send you an email if I find something interesting about Implantica AG.


Comments

How you think about this?

Leave a comment

Stay informed about Implantica AG.

Receive notifications about Implantica AG in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.